Press Releases Pfizer, Inc. Deutsche Boerse AG

Equities

PFE

US7170811035

Market Closed - Deutsche Boerse AG Other stock markets 14:48:29 2024-05-17 EDT			5-day change	1st Jan Change
26.3 ^EUR	-1.22%		+0.79%	+0.75%

05-17	Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	RE
05-17	Sector Update: Health Care Stocks Mixed Late Afternoon	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fitch Affirms and Withdraws Pfizer's Ratings; Outlook Stable	05-16	AQ
When the drugs don't work: Are we overprescribing antidepressants?	05-16	AQ
Small lymphocytic lymphoma Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	05-14	AQ
Pfizer Announces New Chief Strategy and Innovation Officer	05-06	BU
Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR	05-06	AQ
GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents	05-03	AQ
NICE recommends new haemolytic anaemia treatment	05-03	AQ
AM Best Affirms Credit Ratings of Blue Whale Re Ltd	05-03	AQ
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Prepared Remarks	05-02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Infographic	05-02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Press Release	05-02	PU
Pfizer : April Social Media Round-Up—Black Maternal Health, World Immunization, and Long Covid	05-02	PU
Pfizer: Q1 Earnings Snapshot	05-01	AQ
Pfizer Reports First-Quarter 2024 Results	05-01	BU
Pfizer : Goes Live in SXSW’s Podcast Lounge	04-30	PU
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer	04-29	BU
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer	04-29	BU
Novel haemophilia B gene therapy approved	04-29	AQ
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting	04-29	BU
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B	04-26	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm